Johannes Henricus Adrianus Stols
Plus aucun poste en cours
Profil
Johannes Henricus Adrianus Stols formerly worked at Fagron NV, as Chief Executive Officer & Executive Director, European Generic Medicines Association, as Chairman, Vereniging Euro Specialite's, as Chairman, Nederlandse Cystic Fibrosis Stichting, as Chairman, and STADA Arzneimittel AG, as Chief Operating Officer & Director in 2006.
Anciens postes connus de Johannes Henricus Adrianus Stols
| Sociétés | Poste | Fin |
|---|---|---|
| FAGRON N.V. | Directeur Général | 27/11/2017 |
| STADA ARZNEIMITTEL | Directeur des opérations | 01/01/2006 |
| Nederlandse Cystic Fibrosis Stichting | Président | - |
| Vereniging Euro Specialite's | Président | - |
| European Generic Medicines Association | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FAGRON N.V. | Distribution Services |
| Entreprise privées | 4 |
|---|---|
| European Generic Medicines Association | |
| Vereniging Euro Specialite's | |
| Nederlandse Cystic Fibrosis Stichting | |
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: MajorHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
